Kilian Guse, PhD
Dr. Guse is the CEO and co-founder of GeneQuine. He has more than 15 years experience in gene therapy research and development and is author of more than 30 scientific publications in international, peer-reviewed journals and book chapters on this topic.
He holds a PhD in gene therapy from the University of Helsinki, Finland and has done his postdoctoral training in gene therapy at Baylor College of Medicine in Houston, USA. Dr. Guse studied pharmacy at the Goethe University in Frankfurt, Germany.